Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.63)
# 3,122
Out of 4,711 analysts
187
Total ratings
36.71%
Success rate
-5.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVRO Nevro | Downgrades: Underweight | $9 → $4 | $3.79 | +5.54% | 9 | Dec 2, 2024 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $524.43 | +23.94% | 13 | Dec 2, 2024 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $7 → $5 | $3.57 | +40.06% | 15 | Nov 11, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $20.23 | -40.68% | 12 | Jul 15, 2024 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $135 → $130 | $90.39 | +43.82% | 15 | Jul 15, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $130 → $120 | $107.12 | +12.02% | 11 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $61.70 | +53.97% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $81.03 | +20.94% | 9 | Nov 22, 2023 | |
| NARI Inari Medical | Reiterates: Overweight | $83 | $55.45 | +49.68% | 10 | Aug 3, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $84.76 | +0.28% | 9 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $15 | $28.48 | -47.33% | 4 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $325 → $343 | $266.57 | +28.67% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $6.15 | +127.64% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $29.50 | +62.71% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $74.81 | +36.35% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $88.95 | -34.79% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $18.00 | +11.11% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $80.04 | +63.67% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $114.23 | +16.43% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $364.60 | -39.66% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $178.16 | +112.17% | 2 | Feb 25, 2022 |
Nevro
Dec 2, 2024
Downgrades: Underweight
Price Target: $9 → $4
Current: $3.79
Upside: +5.54%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $524.43
Upside: +23.94%
Sight Sciences
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.57
Upside: +40.06%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $20.23
Upside: -40.68%
iRhythm Technologies
Jul 15, 2024
Maintains: Overweight
Price Target: $135 → $130
Current: $90.39
Upside: +43.82%
Zimmer Biomet Holdings
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $130 → $120
Current: $107.12
Upside: +12.02%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $61.70
Upside: +53.97%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $81.03
Upside: +20.94%
Inari Medical
Aug 3, 2023
Reiterates: Overweight
Price Target: $83
Current: $55.45
Upside: +49.68%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $84.76
Upside: +0.28%
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $28.48
Upside: -47.33%
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $266.57
Upside: +28.67%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $6.15
Upside: +127.64%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $29.50
Upside: +62.71%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $74.81
Upside: +36.35%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $88.95
Upside: -34.79%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $18.00
Upside: +11.11%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $80.04
Upside: +63.67%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $114.23
Upside: +16.43%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $364.60
Upside: -39.66%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $178.16
Upside: +112.17%